The Fontan Pathway: Change in Dimension and Catheter-Based Intervention over Time.


Journal

Pediatric cardiology
ISSN: 1432-1971
Titre abrégé: Pediatr Cardiol
Pays: United States
ID NLM: 8003849

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 14 04 2021
accepted: 07 06 2021
pubmed: 18 6 2021
medline: 3 11 2021
entrez: 17 6 2021
Statut: ppublish

Résumé

An unobstructed Fontan pathway is essential for optimal hemodynamics. We hypothesize that more extracardiac conduit (ECC) Fontan pathways develop obstruction compared to lateral tunnel (LT) Fontans and that the dilation typically observed in LTs results in similar mid-term clinical outcomes. A single-center, retrospective study was done including all Fontan cardiac catheterizations from 2006 to 2019. Angiography and medical records were reviewed to define Fontan pathway dimensions, interventions, and clinical outcomes. 232 patients underwent cardiac catheterization, where 60% were ECCs and 30% LTs. The minimum cross-sectional area (CSA) of ECCs was significantly smaller than LTs and LTs dilated over time. 13% of patients had Fontan pathway stenting at a median age of 16.2 years. The minimum CSA for patients who underwent intervention was significantly smaller than patients who did not. Lower weight at Fontan surgery was associated with intervention on the Fontan pathway, with a threshold weight of 15 kg for patients with an ECC. The median follow-up was 3.3 years. Patients who had Fontan pathway intervention were not more likely to experience the composite adverse clinical outcome. LTs were more likely than ECCs to have worse clinical outcome, when liver fibrosis was included. This is the first study to describe angiographic dimensions of the Fontan pathway in a large number of patients over time. ECCs tend to become stenotic. Lower weight at Fontan surgery is a potential risk for Fontan pathway intervention. LTs may experience worse clinical outcomes in follow-up. This information can help inform the optimal timing and method of post-Fontan surveillance.

Identifiants

pubmed: 34136951
doi: 10.1007/s00246-021-02658-2
pii: 10.1007/s00246-021-02658-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1740-1748

Informations de copyright

© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Schilling C, Dalziel K, Nunn R, Du Plessis K, Shi WY, Celermajer D et al (2016) The Fontan epidemic: population projections from the Australia and New Zealand Fontan registry. Int J Cardiol 219:14–19. https://doi.org/10.1016/j.ijcard.2016.05.035
doi: 10.1016/j.ijcard.2016.05.035 pubmed: 27257850
Rychik J, Atz AM, Celermajer DS, Deal BJ, Gatzoulis MA, Gewillig MH et al (2019) Evaluation and management of the child and adult with Fontan circulation: a scientific statement from the American Heart Association. Circulation 140:E234-84. https://doi.org/10.1161/CIR.0000000000000696 (Lippincott Williams and Wilkins [Internet])
doi: 10.1161/CIR.0000000000000696
Dasi LP, KrishnankuttyRema R, Kitajima HD, Pekkan K, Sundareswaran KS, Fogel M et al (2009) Fontan hemodynamics: importance of pulmonary artery diameter. J Thorac Cardiovasc Surg 137(3):560–4. https://doi.org/10.1016/j.jtcvs.2008.04.036
doi: 10.1016/j.jtcvs.2008.04.036 pubmed: 19258065 pmcid: 3631595
Tang E, Restrepo M, Haggerty CM, Mirabella L, Bethel J, Whitehead KK et al (2014) Geometric characterization of patient-specific total cavopulmonary connections and its relationship to hemodynamics. JACC Cardiovascular Imaging 7:215–24. https://doi.org/10.1016/j.jcmg.2013.12.010 (Elsevier Inc.)
doi: 10.1016/j.jcmg.2013.12.010 pubmed: 24529885 pmcid: 3962724
Hagler DJ, Miranda WR, Haggerty BJ, Anderson JH, Johnson JN, Cetta F et al (2019) Fate of the Fontan connection: mechanisms of stenosis and management. Congenit Heart Dis 14(4):571–81. https://doi.org/10.1111/chd.12757
doi: 10.1111/chd.12757 pubmed: 30801968 pmcid: 6850024
Mets JM, Bergersen L, Mayer JE, Marshall AC, McElhinney DB (2013) Outcomes of stent implantation for obstruction of intracardiac lateral tunnel Fontan pathways. Circ Cardiovasc Interv 6(1):92–100. https://doi.org/10.1161/CIRCINTERVENTIONS.112.000099
doi: 10.1161/CIRCINTERVENTIONS.112.000099 pubmed: 23403383
Van Brakel TJ, Schoof PH, De Roo F, Nikkels PGJ, Evens FCM, Haas F (2014) High incidence of Dacron conduit stenosis for extracardiac Fontan procedure. J Thorac Cardiovasc Surg 147(5):1568–72. https://doi.org/10.1016/j.jtcvs.2013.07.013
doi: 10.1016/j.jtcvs.2013.07.013 pubmed: 23988293
Ten Cate FEAU, Trieschmann U, Germund I, Hannes T, Emmel M, Bennink G et al (2017) Stenting the Fontan pathway in paediatric patients with obstructed extracardiac conduits. Heart 103(14):1111–6. https://doi.org/10.1136/heartjnl-2016-310511
doi: 10.1136/heartjnl-2016-310511
Alexi-Meskishvili V, Ovroutski S, Ewert P, Dähnert I, Berger F, Lange PE et al (2000) Optimal conduit size for extracardiac Fontan operation. Eur J Cardio-thoracic Surg 18(6):690–5. https://doi.org/10.1016/s1010-7940(00)00593-5
doi: 10.1016/s1010-7940(00)00593-5
Hoodeshenas S, Yin M, Venkatesh SK (2018) Magnetic resonance elastography of liver current update. Top Magn Reson Imaging 27:319–33. https://doi.org/10.1097/RMR.0000000000000177 (Lippincott Williams and Wilkins [Internet])
doi: 10.1097/RMR.0000000000000177 pubmed: 30289828 pmcid: 6176736
Karlas T, Pfrepper C, Wiegand J, Wittekind C, Neuschulz M, Mössner J et al (2011) Acoustic radiation force impulse imaging (ARFI) for non-invasive detection of liver fibrosis: examination standards and evaluation of interlobe differences in healthy subjects and chronic liver disease. Scand J Gastroenterol 46(12):1458–67. https://doi.org/10.3109/00365521.2011.610004
doi: 10.3109/00365521.2011.610004 pubmed: 21916815
Ben Ali W, Bouhout I, Khairy P, Bouchard D, Poirier N (2019) Extracardiac versus lateral tunnel fontan: a meta-analysis of long-term results. Ann Thorac Surg 107(3):837–43. https://doi.org/10.1016/j.athoracsur.2018.08.041
doi: 10.1016/j.athoracsur.2018.08.041 pubmed: 30315799
Li D, Fan Q, Hirata Y, Ono M, An Q (2017) Arrhythmias after fontan operation with intra-atrial lateral tunnel versus extra-cardiac conduit: a systematic review and meta-analysis. Pediatr Cardiol 38(4):873–880. https://doi.org/10.1007/s00246-017-1595-8
doi: 10.1007/s00246-017-1595-8 pubmed: 28271152
Katogi T (2012) Extracardiac conduit Fontan procedure versus intra-atrial lateral tunnel Fontan procedure. Gen Thorac Cardiovasc Surg 60:792–5. https://doi.org/10.1007/s11748-012-0161-9
doi: 10.1007/s11748-012-0161-9 pubmed: 23229999
Azakie A, McCrindle BW, Van Arsdell G, Benson LN, Coles J, Hamilton R et al (2001) Extracardiac conduit versus lateral tunnel cavopulmonary connections at a single institution: impact on outcomes. J Thorac Cardiovasc Surg 122(6):1219–28. https://doi.org/10.1067/mtc.2001.116947
doi: 10.1067/mtc.2001.116947 pubmed: 11726899
Hsia TY, Migliavacca F, Pittaccio S, Radaelli A, Dubini G, Pennati G et al (2004) Computational fluid dynamic study of flow optimization in realistic models of the total cavopulmonary connections. J Surg Res 116(2):305–13. https://doi.org/10.1016/j.jss.2003.08.004
doi: 10.1016/j.jss.2003.08.004 pubmed: 15013370
Backer CL, Deal BJ, Kaushal S, Russell HM, Tsao S, Mavroudis C (2011) Extracardiac versus intra-atrial lateral tunnel fontan: extracardiac is better. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 14(1):4–10. https://doi.org/10.1053/j.pcsu.2011.01.019
doi: 10.1053/j.pcsu.2011.01.019 pubmed: 21444042
Lin Z, Ge H, Xue J, Wu G, Du J, Hu X et al (2017) Comparison of extracardiac conduit and lateral tunnel for functional single-ventricle patients: a meta-analysis. Congenit Heart Dis 12(6):711–20. https://doi.org/10.1111/chd.12503
doi: 10.1111/chd.12503 pubmed: 28845580
Nürnberg JH, Ovroutski S, Alexi-Meskishvili V, Ewert P, Hetzer R, Lange PE (2004) New onset arrhythmias after the extracardiac conduit fontan operation compared with the intraatrial lateral tunnel procedure: early and midterm results. Ann Thorac Surg 78(6):1979–88. https://doi.org/10.1016/j.athoracsur.2004.02.107
doi: 10.1016/j.athoracsur.2004.02.107 pubmed: 15561013
Robbers-Visser D, Miedema M, Nijveld A, Boersma E, Bogers AJJC, Haas F et al (2010) Results of staged total cavopulmonary connection for functionally univentricular hearts; comparison of intra-atrial lateral tunnel and extracardiac conduit. Eur J Cardio-thoracic Surg 37(4):934–41. https://doi.org/10.1016/j.ejcts.2009.10.016
doi: 10.1016/j.ejcts.2009.10.016
Weixler VHM, Zurakowski D, Kheir J, Guariento A, Kaza AK, Baird CW et al (2020) Fontan with lateral tunnel is associated with improved survival compared with extracardiac conduit. J Thorac Cardiovasc Surg 159:1480-1491.e2. https://doi.org/10.1016/j.jtcvs.2019.11.048 (Mosby Inc.)
doi: 10.1016/j.jtcvs.2019.11.048 pubmed: 31928823
Itatani K, Miyaji K, Tomoyasu T, Nakahata Y, Ohara K, Takamoto S et al (2009) Optimal conduit size of the extracardiac fontan operation based on energy loss and flow stagnation. Ann Thorac Surg 88(2):565–73. https://doi.org/10.1016/j.athoracsur.2009.04.109
doi: 10.1016/j.athoracsur.2009.04.109 pubmed: 19632413
Lee C, Lee CH, Hwang SW, Lim HG, Kim SJ, Lee JY et al (2007) Midterm follow-up of the status of Gore-Tex graft after extracardiac conduit Fontan procedure. Eur J Cardio-thoracic Surg 31(6):1008–1012. https://doi.org/10.1016/j.ejcts.2007.03.013
doi: 10.1016/j.ejcts.2007.03.013
Ochiai Y, Imoto Y, Sakamoto M, Kajiwara T, Sese A, Watanabe M et al (2009) Mid-term follow-up of the status of Gore-Tex graft after extracardiac conduit Fontan procedure. Eur J Cardio-thoracic Surg 36(1):63–8. https://doi.org/10.1016/j.ejcts.2009.02.013
doi: 10.1016/j.ejcts.2009.02.013

Auteurs

E McGovern (E)

Division of Pediatric Cardiology, Department of Pediatrics, University of Kentucky, Lexington, KY, USA. eimear.mcgovern@uky.edu.

T Alsaied (T)

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

N Szugye (N)

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

S Pradhan (S)

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

S P Batlivala (SP)

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

A Lubert (A)

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

R Hirsch (R)

The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH